Europe Fabry Disease Market and Competitive Landscape – 2017

1. Fabry Disease: Disease Overview

1.1. Fabry Disease Symptoms

1.2. Fabry Disease Etiology

1.3. Fabry Disease Diagnosis

1.4. Fabry Disease Treatment Options

2. Fabry Disease Pipeline Insights

2.1. Fabry Disease Phase 3 Clinical Trials

2.2. Fabry Disease Phase 2 Clinical Trials

2.3. Fabry Disease Phase 1 Clinical Trials

3. Fabry Disease Epidemiology Analysis

4. Germany Fabry Disease Market Insights

4.1. Marketed Products for Fabry Disease in Germany

4.2. Germany Fabry Disease Market Size & Forecast

4.3. Germany Fabry Disease Product Sales Forecast

4.4. Germany Fabry Disease Market Share Analysis

5. France Fabry Disease Market Insights

5.1. Marketed Products for Fabry Disease in France

5.2. France Fabry Disease Market Size & Forecast

5.3. France Fabry Disease Product Sales Forecast

5.4. France Fabry Disease Market Share Analysis

6. Italy Fabry Disease Market Insights

6.1. Marketed Products for Fabry Disease in Italy

6.2. Italy Fabry Disease Market Size & Forecast

6.3. Italy Fabry Disease Product Sales Forecast

6.4. Italy Fabry Disease Market Share Analysis

7. Spain Fabry Disease Market Insights

7.1. Marketed Products for Fabry Disease in Spain

7.2. Spain Fabry Disease Market Size & Forecast

7.3. Spain Fabry Disease Product Sales Forecast

7.4. Spain Fabry Disease Market Share Analysis

8. UK Fabry Disease Market Insights

8.1. Marketed Products for Fabry Disease in UK

8.2. UK Fabry Disease Market Size & Forecast

8.3. UK Fabry Disease Product Sales Forecast

8.4. UK Fabry Disease Market Share Analysis

9. Europe Fabry Disease Market Insights

9.1. Europe Fabry Disease Market Size & Forecast

9.2. Europe Fabry Disease Product Sales Forecast

9.3. Europe Fabry Disease Market Share Analysis

10. Research Methodology

LIST OF TABLES

Table 1: Fabry Disease Phase 3 Clinical Trials, Global, 2017

Table 2: Fabry Disease Phase 2 Clinical Trials, Global, 2017

Table 3: Fabry Disease Phase 1 Clinical Trials, Global, 2017

Table 4: Fabry Disease Prevalence by EU5 Countries, 2012 - 2021

Table 5: Marketed Products for Fabry Disease in Germany, 2017

Table 6: Germany Fabry Disease Market Size & Forecast ($mn), 2012 - 2021

Table 7: Germany Fabry Disease Product Sales ($mn), 2012 - 2021

Table 8: Germany Fabry Disease Market Trends, 2012 - 2021

Table 9: Marketed Products for Fabry Disease in France, 2017

Table 10: France Fabry Disease Market Size & Forecast ($mn), 2012 - 2021

Table 11: France Fabry Disease Product Sales ($mn), 2012 - 2021

Table 12: France Fabry Disease Market Trends, 2012 - 2021

Table 13: Marketed Products for Fabry Disease in Italy, 2017

Table 14: Italy Fabry Disease Market Size & Forecast ($mn), 2012 - 2021

Table 15: Italy Fabry Disease Product Sales ($mn), 2012 - 2021

Table 16: Italy Fabry Disease Market Trends, 2012 - 2021

Table 17: Marketed Products for Fabry Disease in Spain, 2017

Table 18: Spain Fabry Disease Market Size & Forecast ($mn), 2012 - 2021

Table 19: Spain Fabry Disease Product Sales ($mn), 2012 - 2021

Table 20: Spain Fabry Disease Market Trends, 2012 - 2021

Table 21: Marketed Products for Fabry Disease in UK, 2017

Table 22: UK Fabry Disease Market Size & Forecast ($mn), 2012 - 2021

Table 23: UK Fabry Disease Product Sales ($mn), 2012 - 2021

Table 24: UK Fabry Disease Market Trends, 2012 - 2021

Table 25: Europe Fabry Disease Market Size & Forecast ($mn), 2012 - 2021

Table 26: Europe Fabry Disease Product Sales ($mn), 2012 - 2021

LIST OF FIGURES

Figure 1: Fabry Disease Pipeline by Phase (%), Global, 2017

Figure 2: Fabry Disease Prevalence by EU5 Countries, 2012 - 2021

Figure 3: Germany Fabry Disease Market Size ($mn), 2012 - 2021

Figure 4: Germany Fabry Disease Product Sales ($mn), 2012 - 2021

Figure 5: Germany Fabry Disease Market Share by Products (%), 2016

Figure 6: Germany Fabry Disease Market - Future Market Share (%), 2021

Figure 7: France Fabry Disease Market Size ($mn), 2012 - 2021

Figure 8: France Fabry Disease Product Sales ($mn), 2012 - 2021

Figure 9: France Fabry Disease Market Share by Products (%), 2016

Figure 10: France Fabry Disease Market - Future Market Share (%), 2021

Figure 11: Italy Fabry Disease Market Size ($mn), 2012 - 2021

Figure 12: Italy Fabry Disease Product Sales ($mn), 2012 - 2021

Figure 13: Italy Fabry Disease Market Share by Products (%), 2016

Figure 14: Italy Fabry Disease Market - Future Market Share (%), 2021

Figure 15: Spain Fabry Disease Market Size ($mn), 2012 - 2021

Figure 16: Spain Fabry Disease Product Sales ($mn), 2012 - 2021

Figure 17: Spain Fabry Disease Market Share by Products (%), 2016

Figure 18: Spain Fabry Disease Market - Future Market Share (%), 2021

Figure 19: UK Fabry Disease Market Size ($mn), 2012 - 2021

Figure 20: UK Fabry Disease Product Sales ($mn), 2012 - 2021

Figure 21: UK Fabry Disease Market Share by Products (%), 2016

Figure 22: UK Fabry Disease Market - Future Market Share (%), 2021

Figure 23: Europe Fabry Disease Market Size ($mn), 2012 - 2021

Figure 24: Europe Fabry Disease Product Sales ($mn), 2012 - 2021

Figure 25: Europe Fabry Disease Market Share by Products (%), 2016

Figure 26: Europe Fabry Disease Market - Future Market Share (%), 2021

Europe Fabry Disease Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Fabry Disease Market and Competitive Landscape – 2017, provides comprehensive insights into Fabry Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Fabry Disease market size and drug sales. This research also provides insights into Fabry Disease epidemiology and late stage pipeline.
The report is classified into nine sections – Fabry Disease overview with definitions, symptoms, etiology, diagnosis, treatment options; Fabry Disease pipeline insights covering late stage clinical trials pipeline; Fabry Disease prevalence trends by countries; Fabry Disease market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

• Fabry Disease pipeline: Find out the drugs in clinical trials for Fabry Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Fabry Disease epidemiology: Find out the prevalence of Fabry Disease by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
• Fabry Disease products: Identify key products marketed and prescribed for Fabry Disease by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
• Fabry Disease market size: Find out the market size for Fabry Disease drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
• Fabry Disease drug sales: Find out the sales of Fabry Disease drugs by countries – Europe, Germany, France, Italy, Spain, UK
• Fabry Disease drugs sales forecast: Sales forecast for Fabry Disease drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
• Fabry Disease market share analysis: Find out the market shares of Fabry Disease drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

• Evaluate commercial market opportunities for Fabry Disease drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Fabry Disease market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Fabry Disease market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies